Search

Ingelvac CircoFLEX

For the active immunisation of pigs over the age of two weeks against porcine circovirus type 2 to reduce mortality, clinical signs – including weight loss – and lesions in lymphoid tissues associated with porcine circovirus diseases (PCVD).

STOP Rabies: moving towards elimination

Rabies still kills thousands of people every year. However, rabies is 100 percent vaccine preventable. We contribute to eliminating the disease.

Boehringer Ingelheim advances SIRP immune-oncology program

Boehringer and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371

Pulmonary Fibrosis

Patient Centricity

Our Responsibility

Human Health Our Responsibility

Cat vaccination 10 things you should know

Find out how you can keep your feline companion happy and healthy.

Zongertinib positive results non-small cell lung cancer

Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients

Annual Results Press Conference

Boehringer Ingelheim presents the results of business development and gives an outlook for the coming year.

RE-LY-trial-publication-10-year-anniversary

Boehringer Ingelheim recognises the contribution made in the decade since the RE-LY® trial publication by patients, HCPs and researchers

Podcast: Journeys through pulmonary fibrosis

As we speak to the courageous pulmonary fibrosis community, we hear heart-warming stories of determination, resilience and spirit.

New partnership to develop schizophrenia treatments

Boehringer Ingelheim partners with Sosei Heptares to develop next generation schizophrenia treatments

Breakthrough introduction innovation pet parasiticides

In 2014, Boehringer introduced a new product, which became the first in a new class of isoxazoline products for flea and tick protection in dogs.

Pet parasites are still here. What's the risk?

What's the risk of pet parasites? They’re a growing challenge due to climate change. Check how to protect your dog and cat from fleas, ticks and more.

Generalised-Pustular-Psoriasis-Infographic

What is GPP? GPP is a rare and chronic autoinflammatory skin disease with recurrent episodes of exacerbations or flares

Exploring beyond boundaries for innovation in animal health

Exploring beyond boundaries by partnering with human pharma and animal health may hold the key to accelerating innovation in animal health.

More Than Scleroderma

A hub of knowledge, advice and support for those whose lives have been touched by scleroderma.

Hidradenitis suppurativa

Find out more about hidradenitis suppurativa (HS), a long-term, inflammatory, recurrent, skin disease

Generalized pustular psoriasis is not ‘sensitive’ content

Learn about the impact that a lack of online visibility can have on people living with this chronic, inflammatory skin disease.

ACR19 Autoimmune Trial

ACR Congress 2019 abstract analysing a subgroup of patients with autoimmune diseases in the INBUILD® trial of nintedanib in patients with PF-ILF

Facts about the INPULSIS™ trials

1885-1948: Innovative beginnings

The Boehringer Ingelheim history from its start in 1885 to 1948, with milestones and important products

Uniting to stop rabies: a global and local endeavor

By collaborating together, we can stop rabies. Read how we are breaking down barriers through the power of partnerships to fight this deadly disease

History

Living with type 2 diabetes

People living with type 2 diabetes often suffer a degree of stigma. Learn from Jurjen de Lange what it takes to live a good life despite the disease.

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers